Dr Agarwal’s Health Care Records Impressive Q1 Net Profit of Rs 17.26 Crore

Dr Agarwal’s Health Care Ltd has reported a net profit of Rs 17.26 crore for the April-June 2025 quarter, driven by robust performance and expansion of its eye care network. The city-based firm earned a net profit of Rs 14.11 crore during the corresponding quarter of the last fiscal, marking a significant increase in profitability.

Key Highlights of Q1 Results

The total income for the quarter under review surged to Rs 117.72 crore, from Rs 100.42 crore registered in the year-ago period. For the financial year ending March 31, 2025, the total income was at Rs 402.24 crore. The company’s consolidated net profit for the year ending March 31, 2025, was at Rs 54.65 crore.

CEO’s Commentary on Q1 Performance

Commenting on the financial performance, Dr Agarwal’s Health Care Ltd CEO, Dr Adil Agarwal, said, “The first quarter of the new fiscal year has started with a robust performance.” “We are pleased to report the highest-ever revenue on a quarterly basis, with profit margins sustaining at high levels. Total income for the quarter stood at Rs 501 crore, a growth of 22.3% over the same period of last year driven by healthy growth across our network,” he added.

Operational Updates and Expansion Plans

Agarwal said, “Operationally, our network grew to 249 eye care facilities as of June 30, 2025, with 13 additions during the quarter. We also marked our strategic entry into the Delhi market, opening our first centre in the capital to strengthen our presence in North India.” “We remain committed to expanding our footprint, investing in advanced technologies, and delivering superior clinical outcomes to our patients,” he said.

Surgeries and Revenue Breakup

During the April-June 2025 quarter, Dr Agarwal’s Health added 1 tertiary, 7 secondary, and 5 primary care facilities. It performed 78,882 surgeries during the quarter under review, up by 16% year-on-year basis. The sales of services during the quarter under review contributed 78.6%, while the sale of products accounted for 21.4% to the revenue from operations.

Investor Takeaways and Future Outlook

The impressive Q1 results of Dr Agarwal’s Health Care Ltd are a testament to the company’s strong fundamentals and growth potential. With its expanding network of eye care facilities and commitment to delivering superior clinical outcomes, the company is well-positioned to capitalize on the growing demand for healthcare services in India.

Investors looking to tap into the growth potential of the healthcare sector may consider Dr Agarwal’s Health Care Ltd as a promising investment opportunity. However, it is essential to conduct thorough research and analysis before making any investment decisions.

For more information on Indian stock market news and updates on Q1 results, please visit our website.